World Condoms – Market Analysis, Forecast, Size, Trends and Insights
$4,000
License:
Limited to one named user
What you get
- Full report in PDF · Excel data package · Word document · Executive presentation
- Email delivery 24/7, including weekends and holidays
- Copy-and-paste enabled · print-ready format
- Unlimited clarification rounds after delivery
Condoms Market Forecast to 2035: Premiumization and E-Commerce to Drive Growth
Abstract
According to the latest IndexBox report on the global Condoms market, the market enters 2026 with broader demand fundamentals, more disciplined procurement behavior, and a more regionally diversified supply architecture.
The global condoms market is undergoing a fundamental transformation from a functional prophylactic category to a dynamic component of the broader sexual wellness landscape. Between 2026 and 2035, growth will be driven by premiumization, discreet e-commerce adoption, and the expansion of usage occasions beyond contraception into experience-enhancing sexual health. The market is bifurcated: a high-volume, price-sensitive commodity tier dominated by private label, and a premium, benefit-driven segment focused on sensation, material innovation, and lifestyle branding.
Private label has secured a defensible position in the commodity tier through superior retailer margins, forcing national brands to innovate up the value ladder or engage in price wars. Control of physical and digital point-of-sale is the critical competitive bottleneck, with shelf placement and e-commerce discoverability dictating market share more than brand awareness alone. The supply chain remains globalized and concentrated, vulnerable to input cost volatility and regulatory shifts. Innovation is incremental but meaningful, focusing on material science and sensory claims to justify premium price points.
Geographic strategies must differentiate between high-volume public health markets and high-value premiumization markets. The long-term outlook hinges on the tension between commoditization pressure and the margin-rich potential of sexual wellness and discreet convenience segments.
The baseline scenario for the global condoms market from 2026 to 2035 anticipates steady value growth, with a CAGR of 5.8%, reaching a market index of 158 by 2035 (2025=100). This outlook assumes continued premiumization in developed markets, rising e-commerce penetration, and gradual recovery in public health procurement. Volume growth will be modest, particularly in mature markets where contraception prevalence is high and birth rates are low, but value growth will outpace volume as consumers trade up to premium materials, ultra-thin variants, and feature-enhanced products.
The commodity tier will remain under pressure from private label, which commands a dominant share in retail and limits pricing power for national brands. However, the premium and sexual wellness segments will expand, supported by changing social attitudes, increased openness, and the integration of condoms into broader wellness routines. E-commerce and DTC channels will grow disproportionately, driven by subscription models, discreet purchasing, and bundling with other sexual wellness products. Emerging markets in Asia-Pacific and Latin America will offer volume opportunities, though price sensitivity will constrain value growth.
Regulatory shifts, particularly in production and distribution, could impact supply chains, but overall demand fundamentals remain positive. The market will increasingly diverge between high-volume, low-margin public health segments and high-value, brand-centric premium segments, requiring tailored strategies for each.
Demand Drivers and Constraints
Primary Demand Drivers
- Premiumization and trade-up to non-latex materials, ultra-thin designs, and sensory-enhanced products
- Discreet e-commerce and DTC subscription models expanding access and repeat purchase
- Expansion of usage occasions beyond contraception into sexual wellness and experience enhancement
- Rising sexual health awareness and education in emerging markets
- Public health procurement programs for STI/HIV prevention in high-burden regions
- Innovation in material science and lubricant technology enabling new claims and price tiers
Potential Growth Constraints
- Intense price competition from private label eroding national brand margins
- Regulatory and cultural barriers limiting category marketing and distribution in some regions
- Volatility in raw material costs (natural rubber latex, synthetic polymers) impacting profitability
- Stigma and misinformation reducing adoption in certain demographic and geographic segments
- Supply chain concentration in a few manufacturing hubs creating vulnerability to disruptions
Demand Structure by End-Use Industry
Contraception (estimated share: 45%)
Contraception remains the largest use case for condoms globally, driven by the need for pregnancy prevention and dual protection against STIs. In developed markets, high contraceptive prevalence and the availability of alternative methods (oral contraceptives, IUDs, implants) limit volume growth, but condoms retain a critical role as the only method offering STI protection. In emerging markets, rising awareness, government family planning programs, and expanding access through retail and public health channels support demand. Through 2035, the segment will see a gradual shift from commodity latex products to premium and non-latex options, as consumers seek greater comfort and sensitivity.
Demand-side indicators include contraceptive prevalence rates, unmet need for family planning, and public health expenditure on STI/HIV prevention. The segment’s value growth will be moderate, constrained by price sensitivity in high-volume markets, but premiumization within contraception will lift average selling prices. Private label will continue to dominate the commodity tier, while brands focus on differentiated benefits to justify higher price points. Current trend: stable to slightly declining share as other segments grow faster.
Major trends: Shift from latex to non-latex materials for enhanced sensation and allergy avoidance, Growing integration of condoms into comprehensive sexual health programs, Public health procurement driving volume in low-income countries, Premiumization within contraception as consumers seek better experience, and Private label dominance in the commodity tier pressuring brand pricing.
Representative participants: Reckitt Benckiser (Durex), Church & Dwight (Trojan), Karex Berhad, Okamoto Industries, and Humanwell Healthcare (Jissbon).
STI/HIV Prevention (estimated share: 25%)
The STI/HIV prevention segment encompasses both public health procurement and individual purchase for disease protection. Globally, condoms remain the most effective method for preventing sexually transmitted infections, including HIV. Demand is heavily influenced by public health initiatives, donor funding, and awareness campaigns. In high-burden regions, particularly sub-Saharan Africa, international organizations and governments distribute billions of condoms annually, though funding fluctuations can cause volatility. In developed markets, rising STI rates among certain demographics have renewed focus on condom use, supported by targeted marketing and education.
Through 2035, demand will be sustained by ongoing prevention efforts, but growth will depend on funding stability and the integration of condoms with other prevention technologies (e.g., PrEP). Demand-side indicators include STI incidence rates, HIV prevalence, donor funding levels, and awareness campaign reach. The segment is less price-sensitive in public health procurement but highly competitive, with bulk tenders favoring low-cost suppliers. Branded products play a smaller role, though social marketing brands bridge public health and commercial channels. Current trend: growing share due to increased public health focus and awareness.
Major trends: Increased public health funding for HIV/STI prevention in high-burden regions, Integration of condoms with PrEP and other combination prevention strategies, Rising STI rates in developed markets driving renewed condom promotion, Social marketing brands expanding access in emerging markets, and Shift toward bulk procurement and low-cost manufacturing.
Representative participants: Karex Berhad, Thai Nippon Rubber Industry, Fuji Latex Indonesia, Guilin Latex Factory, and Mayer Laboratories.
Sexual Wellness and Enhancement (estimated share: 20%)
The sexual wellness and enhancement segment represents the most dynamic and margin-rich part of the condom market. Here, condoms are positioned not merely as protection but as tools for enhancing pleasure, intimacy, and sexual health. Products feature ultra-thin materials, textured surfaces, warming or cooling lubricants, and ergonomic designs. Demand is driven by changing social attitudes, greater openness about sexuality, and the influence of social media and pop culture. Consumers in this segment are less price-sensitive and more brand-loyal, seeking products that align with their lifestyle and values. E-commerce and DTC channels are particularly important, offering discreet purchasing and subscription convenience.
Through 2035, this segment will outpace overall market growth, fueled by innovation in materials and sensory technologies, as well as the expansion of sexual wellness into mainstream retail. Demand-side indicators include spending on sexual wellness products, e-commerce penetration, and brand engagement metrics. Major brands are investing heavily in this space, while challenger brands disrupt with niche propositions. Current trend: fastest-growing segment, driven by premiumization and lifestyle branding.
Major trends: Ultra-thin and non-latex materials for enhanced sensation, Sensory features such as heat, texture, and flavored lubricants, Subscription and DTC models for discreet repeat purchase, Bundling with other sexual wellness products (lubricants, toys), and Influencer marketing and social media driving brand discovery.
Representative participants: Reckitt Benckiser (Durex), Church & Dwight (Trojan), Okamoto Industries, Sagami Rubber Industries, and Humanwell Healthcare (Jissbon).
Family Planning and Reproductive Health (estimated share: 7%)
The family planning and reproductive health segment overlaps with contraception but focuses on organized programs by governments, NGOs, and international agencies. Condoms are a key component of comprehensive family planning services, particularly in regions with high unmet need for contraception. Demand is driven by population growth, government health policies, and international development goals. In many low- and middle-income countries, condoms are provided free or at subsidized prices through public health facilities and community distribution networks. This segment is characterized by bulk procurement, low margins, and dependence on donor funding.
Through 2035, demand will grow in line with population growth and efforts to increase contraceptive prevalence, but funding constraints and shifting priorities may limit expansion. Demand-side indicators include unmet need for family planning, contraceptive prevalence rates, and government health expenditure. The segment is less brand-driven, with manufacturers competing on price and reliability. Social marketing programs sometimes use branded condoms to cross-subsidize free distribution. Current trend: stable, with growth tied to government programs and NGO initiatives.
Major trends: Integration of condoms into broader reproductive health services, Increased focus on youth-friendly distribution channels, Donor funding shifts impacting supply in low-income countries, Public-private partnerships expanding access, and Growing demand for dual protection (pregnancy and STI prevention).
Other (Novelty, Specialty, and Online-Only) (estimated share: 3%)
The ‘other’ segment encompasses novelty condoms, specialty products (e.g., vegan, sustainable, custom-fit), and online-only brands. While small in volume, this segment is growing rapidly due to e-commerce and changing consumer preferences. Novelty condoms are often purchased for humor or as gifts, while specialty products cater to niche audiences seeking specific attributes like eco-friendliness or unique sizing. Online-only brands leverage DTC models to offer discreet purchasing, subscription services, and personalized recommendations. Demand is driven by younger, digitally native consumers who value convenience, privacy, and brand authenticity.
Through 2035, this segment will benefit from the continued shift to online shopping and the proliferation of sexual wellness startups. Demand-side indicators include e-commerce penetration, social media engagement, and startup funding. Major players are typically small, agile brands, though larger companies are acquiring or launching niche lines to capture this growth. The segment is characterized by higher margins but lower volumes, with success dependent on effective digital marketing and community building. Current trend: niche but growing, driven by e-commerce and customization.
Major trends: Rise of DTC and online-only brands targeting niche audiences, Demand for sustainable and vegan condoms, Custom-fit and personalized condom offerings, Novelty and gift-oriented products for special occasions, and Social media and influencer-driven discovery.
Representative participants: Sustain Natural, Lola, Maude, One Condoms, and Glyde.
Key Market Participants
Interactive table based on the Store Companies dataset for this report.
| # | Company | Headquarters | Focus | Scale | Note |
|---|---|---|---|---|---|
| 1 | Reckitt Benckiser Group plc | Slough, United Kingdom | Consumer health & hygiene brands | Global | Owns Durex, market leader globally |
| 2 | Church & Dwight Co., Inc. | Ewing, New Jersey, USA | Consumer products | Global | Owns Trojan, leading brand in North America |
| 3 | Okamoto Industries, Inc. | Tokyo, Japan | Rubber & plastic products | Global | Major manufacturer, owns Okamoto brand |
| 4 | Mayer Laboratories, Inc. | San Francisco, California, USA | Sexual health products | Major | Owns Lifestyles and SKYN brands |
| 5 | Fuji Latex Co., Ltd. | Tokyo, Japan | Condom manufacturing | Major | Major OEM manufacturer and brand owner |
| 6 | Sagami Rubber Industries Co., Ltd. | Kanagawa, Japan | Condom manufacturing | Major | Known for Sagami brand and thin condoms |
| 7 | Karex Berhad | Port Klang, Malaysia | Condom manufacturing | Global | World’s largest condom manufacturer by volume |
| 8 | Guangzhou Daming United Rubber Products Co., Ltd. | Guangzhou, China | Condom manufacturing | Major | Major Chinese manufacturer |
| 9 | HLL Lifecare Limited | Thiruvananthapuram, India | Healthcare products | Major | Manufactures Moods and Nirodh brands |
| 10 | Veru Inc. | Miami, Florida, USA | Healthcare & biopharma | Major | Owns FC2 Female Condom brand |
| 11 | Ansell Limited | Richmond, Victoria, Australia | Protection solutions | Global | Sells condoms under various brands |
| 12 | TTK Protective Devices Limited | Chennai, India | Condom manufacturing | Major | Manufactures Kamasutra brand |
| 13 | Guilin Latex Co., Ltd. | Guilin, China | Condom manufacturing | Major | State-owned Chinese manufacturer |
| 14 | Humanwell Healthcare Group Co., Ltd. | Wuhan, China | Pharmaceuticals & medical devices | Major | Owns Jissbon brand |
| 15 | Cupid Limited | Mumbai, India | Condom & sexual wellness products | Major | Manufacturer and exporter |
| 16 | Mithra Pharmaceuticals SA | Liege, Belgium | Women’s health | Major | Owns female condom brands |
Regional Dynamics
Asia-Pacific (estimated share: 35%)
Largest and fastest-growing region, driven by population size, rising awareness, and expanding e-commerce. China and India are key markets, with premiumization in urban centers and public health programs in rural areas. Local brands dominate, but international players are gaining share. Direction: growing.
North America (estimated share: 25%)
Mature market with high contraceptive prevalence. Growth is driven by premiumization, sexual wellness trends, and e-commerce. Private label is strong, but brands like Trojan and Durex lead in premium segments. STI prevention remains a focus. Direction: stable with premiumization.
Europe (estimated share: 20%)
Mature market with high awareness and acceptance. Growth is slow but steady, supported by premiumization and sexual wellness. E-commerce is significant, and private label is prevalent. Regulatory environment is stringent, favoring quality and safety. Direction: stable with moderate growth.
Latin America (estimated share: 12%)
Growing market with increasing contraceptive prevalence and government programs. Brazil and Mexico are key. Price sensitivity is high, but premium segments are emerging. E-commerce is expanding, though traditional retail remains dominant. Direction: growing.
Middle East & Africa (estimated share: 8%)
High potential but constrained by cultural and regulatory barriers. Public health programs drive volume in sub-Saharan Africa. Rising awareness and urbanization support gradual growth. E-commerce is nascent but growing in urban areas. Direction: growing from a small base.
Market Outlook (2026-2035)
In the baseline scenario, IndexBox estimates a 5.8% compound annual growth rate for the global condoms market over 2026-2035, bringing the market index to roughly 158 by 2035 (2025=100).
Note: indexed curves are used to compare medium-term scenario trajectories when full absolute volumes are not publicly disclosed.
For full methodological details and benchmark tables, see the latest IndexBox Condoms market report.
This report is an independent strategic category study of the global market for Condoms. It is designed for brand owners, general managers, category leaders, trade-marketing teams, e-commerce teams, retail partners, distributors, investors, and market entrants that need a clear read on where growth sits, which brands control the category, how pricing and promotion shape demand, and which channels matter most for scale and margin.
The framework is built for Consumer Health & Wellness Goods markets within consumer goods, where performance is driven by need states, shopper missions, brand hierarchies, price-pack architecture, retail execution, promotional intensity, and route-to-market control rather than by a narrow technical specification alone. It defines Condoms as Consumer-grade prophylactic devices for sexual health and pregnancy prevention, sold primarily through retail and e-commerce channels and maps the market through category boundaries, consumer segments, usage occasions, channel structure, brand and private-label positions, supply and availability logic, pricing and promotion mechanics, and country-level commercial roles. Historical analysis typically covers 2012 to 2025, with forward-looking scenarios through 2035.
What questions this report answers
This report is designed to answer the questions that matter most to brand, category, channel, and strategy teams in consumer-goods markets.
- Where category growth and margin pools really sit: how large the market is, which segments are growing, and which parts of the category carry the strongest commercial upside.
- What the category actually includes: where the scope boundary should be drawn relative to adjacent products, substitute baskets, and wider household or personal-care routines.
- Which commercial segments matter most: how the category should be cut by format, need state, shopper occasion, price tier, pack architecture, channel, and brand position.
- How shoppers enter, repeat, trade up, and switch: which need states and shopping missions create the strongest value pools, and what drives loyalty versus substitution.
- Which brands control volume, premium mix, and shelf power: how branded players, challengers, and private label differ in scale, positioning, channel strength, and claims authority.
- How pricing and promotion really work: how price ladders, pack-price logic, promotions, and channel margin structures shape revenue quality and competitive intensity.
- How supply and route-to-market affect performance: where manufacturing, private label, fulfillment, replenishment, and on-shelf availability create advantage or risk.
- Which countries and channels matter most for growth: where to build brand power, where to source or manufacture, and where the next wave of category expansion is likely to come from.
- Where the best white-space opportunities are: which segments, countries, channels, and assortment gaps are most attractive for entry, expansion, or portfolio repositioning.
What this report is about
At its core, this report explains how the market for Condoms actually works as a consumer category. It is built to show where demand comes from, which need states and shopper missions matter most, which brands and private-label players shape the category, which channels control visibility and conversion, and where pricing power, repeat purchase, and margin are actually created.
Rather than framing the category through narrow technical attributes, the study breaks it into decision-grade commercial layers: product format, benefit platform, shopper segment, purchase occasion, pack-price architecture, channel environment, promotional intensity, route-to-market control, and company archetype. It is therefore useful both for teams shaping portfolio strategy and for teams executing growth through Individual Consumers, Retailers & Pharmacies, E-commerce Platforms, Public Health Bodies, and Corporate Wellness Programs.
The report also clarifies how value pools differ across Contraception, STI Prevention, and Enhanced Sexual Experience, how premiumization and private label reshape category economics, how retail concentration and route-to-market design affect scale, and which countries matter most for brand building, sourcing, packaging, and channel expansion.
Research methodology and analytical framework
The report is based on an independent market-intelligence methodology that combines category reconstruction, public company evidence, retail and channel mapping, pricing review, and multi-layer triangulation. It is built for consumer categories where no single public dataset captures the real structure of demand, brand power, promotion, and channel control.
The evidence stack typically combines company disclosures, investor materials, brand and retailer product pages, e-commerce assortment checks, packaging and claims analysis, public pricing references, trade statistics where relevant, regulatory and labeling guidance, and observable route-to-market evidence from distributors, retailers, merchandisers, and marketplace ecosystems.
The analytical model then reconstructs the category across the layers that matter commercially: category scope, shopper need states, consumer segments, pack-price ladders, brand and private-label hierarchy, channel power, promotional intensity, route-to-market design, and country role differences.
Special attention is given to Public Health Awareness & Campaigns, Disposable Income & Premiumization, Discreet E-commerce Growth, Sexual Wellness Destigmatization, Travel & Hospitality Recovery, and Private Label Expansion. The objective is not only to size the market, but to explain where value pools sit, which segments drive mix and repeat purchase, which channels shape growth, and how leading brands defend or expand their positions across Individual Consumers, Retailers & Pharmacies, E-commerce Platforms, Public Health Bodies, and Corporate Wellness Programs.
The report does not rely on survey-based opinion as its core evidence base. Instead, it uses observable commercial signals and structured public evidence to build a decision-grade view for brand, category, retail, e-commerce, investment, and market-entry teams.
Commercial lenses used in this report
- Need states, benefit platforms, and usage occasions: Contraception, STI Prevention, and Enhanced Sexual Experience
- Shopper segments and category entry points: Consumer Retail, Public Health Programs, and Hospitality (Hotels)
- Channel, retail, and route-to-market structure: Individual Consumers, Retailers & Pharmacies, E-commerce Platforms, Public Health Bodies, and Corporate Wellness Programs
- Demand drivers, repeat-purchase logic, and premiumization signals: Public Health Awareness & Campaigns, Disposable Income & Premiumization, Discreet E-commerce Growth, Sexual Wellness Destigmatization, Travel & Hospitality Recovery, and Private Label Expansion
- Price ladders, promo mechanics, and pack-price architecture: Ultra-Economy/Public Health, Value/Private Label, Mainstream/Mass-Market Branded, Premium/Specialty, and Prestige/Designer & DTC
- Supply, replenishment, and execution watchpoints: Raw Material (Latex) Price Volatility, High-Capacity Manufacturing Certification, Regulatory Compliance & Testing Lead Times, and Shelf-Space Competition in Key Retail Channels
Product scope
This report defines Condoms as Consumer-grade prophylactic devices for sexual health and pregnancy prevention, sold primarily through retail and e-commerce channels and treats it as a branded consumer category rather than as a narrow technical product class. The objective is to capture the real commercial market that category, brand, trade-marketing, and channel teams are managing.
Scope is determined by how the category is sold, merchandised, priced, and chosen in market. That means the report follows product formats, claims, price tiers, pack architecture, need states, and retail environments that shape Contraception, STI Prevention, and Enhanced Sexual Experience.
The study deliberately separates the category from adjacent baskets when they distort the economics or shopper logic of the market being measured. Typical exclusions therefore include Medical-grade surgical gloves, Industrial latex products, Prescription-based contraceptives (IUDs, implants), Fertility tracking devices, Wholesale bulk condoms for institutional programs (unless also sold via retail), Personal lubricants (sold separately), Sex toys, Pregnancy tests, STI test kits, and Sexual enhancement supplements.
Product-Specific Inclusions
- Latex condoms
- Non-latex condoms (polyurethane, polyisoprene)
- Textured/ribbed condoms
- Flavored condoms
- Lubricated condoms
- Thin/ultra-thin variants
- Glow-in-the-dark/novelty condoms
- Retail-packed consumer units (3-packs, 12-packs, etc.)
Product-Specific Exclusions and Boundaries
- Medical-grade surgical gloves
- Industrial latex products
- Prescription-based contraceptives (IUDs, implants)
- Fertility tracking devices
- Wholesale bulk condoms for institutional programs (unless also sold via retail)
Adjacent Products Explicitly Excluded
- Personal lubricants (sold separately)
- Sex toys
- Pregnancy tests
- STI test kits
- Sexual enhancement supplements
Geographic coverage
The report provides global coverage. It evaluates the world market as a whole and then breaks it down by region and country, with particular focus on the geographies that matter most for consumer demand, brand development, manufacturing, retail concentration, and route-to-market control.
The geographic analysis is designed not simply to rank countries by nominal market size, but to classify them by role in the category. Depending on the product, countries may function as:
- large-scale consumer-demand and brand-building markets;
- manufacturing and sourcing bases with packaging, formulation, or cost advantages;
- retail and e-commerce innovation markets where channel shifts happen first;
- premiumization and claim-led markets that influence product architecture and positioning;
- import-reliant growth markets where distribution, merchandising, and local partnerships matter most.
Geographic and Country-Role Logic
- High-Consumption Mature Markets
- High-Growth Emerging Markets
- Commodity Raw Material Producers
- Low-Cost Manufacturing Hubs
- Regional Regulatory & Distribution Hubs
Who this report is for
This study is designed for strategic and commercial users across brand-led consumer categories, including:
- general managers, brand leaders, and portfolio teams evaluating category attractiveness, pricing power, and whitespace;
- category managers, trade-marketing teams, retail buyers, and e-commerce teams prioritizing assortment, promotion, and channel strategy;
- insights, shopper-marketing, and innovation teams tracking need states, occasions, pack-price ladders, claims, and competitive messaging;
- private-label and contract-manufacturing strategists assessing entry options, retailer leverage, and supply-side positioning;
- distributors and route-to-market teams evaluating country and channel expansion priorities;
- investors and strategy teams benchmarking competitive structure, premiumization, revenue quality, and margin logic.
Why this approach matters in consumer categories
In many brand-driven, channel-sensitive, and consumer-demand-led markets, official trade and production statistics are not sufficient on their own to describe the true market. Product boundaries may cut across multiple tariff codes, several product categories may be bundled into the same official classification, and a meaningful share of activity may take place through customized services, captive supply, platform relationships, or technically specialized channels that are not directly visible in standard statistical datasets.
For this reason, the report is designed as a modeled strategic market study. It uses official and public evidence wherever it is reliable and scope-compatible, but it does not force the market into a purely statistical framework when doing so would reduce analytical quality. Instead, it reconstructs the market through the logic of demand, supply, technology, country roles, and company behavior.
This makes the report particularly well suited to products that are innovation-intensive, technically differentiated, capacity-constrained, platform-dependent, or commercially structured around specialized buyer-supplier relationships rather than standardized commodity trade.
Typical outputs and analytical coverage
The report typically includes:
- historical and forecast market size;
- consumer-demand, shopper-mission, and need-state analysis;
- category segmentation by format, benefit platform, channel, price tier, and pack architecture;
- brand hierarchy, private-label pressure, and competitive-structure analysis;
- route-to-market, retail, e-commerce, and availability logic;
- pricing, promotion, trade-spend, and revenue-quality interpretation;
- country role mapping for brand building, sourcing, and expansion;
- major-brand and company archetypes;
- strategic implications for brand owners, retailers, distributors, and investors.
Reckitt Benckiser Group plc
Headquarters
Slough, United Kingdom
Focus
Consumer health & hygiene brands
Scale
Global
Owns Durex, market leader globally
Church & Dwight Co., Inc.
Headquarters
Ewing, New Jersey, USA
Focus
Consumer products
Scale
Global
Owns Trojan, leading brand in North America
Okamoto Industries, Inc.
Headquarters
Tokyo, Japan
Focus
Rubber & plastic products
Scale
Global
Major manufacturer, owns Okamoto brand
Mayer Laboratories, Inc.
Headquarters
San Francisco, California, USA
Focus
Sexual health products
Scale
Major
Owns Lifestyles and SKYN brands
Fuji Latex Co., Ltd.
Headquarters
Tokyo, Japan
Focus
Condom manufacturing
Scale
Major
Major OEM manufacturer and brand owner
Sagami Rubber Industries Co., Ltd.
Headquarters
Kanagawa, Japan
Focus
Condom manufacturing
Scale
Major
Known for Sagami brand and thin condoms
Karex Berhad
Headquarters
Port Klang, Malaysia
Focus
Condom manufacturing
Scale
Global
World’s largest condom manufacturer by volume
Guangzhou Daming United Rubber Products Co., Ltd.
Headquarters
Guangzhou, China
Focus
Condom manufacturing
Scale
Major
HLL Lifecare Limited
Headquarters
Thiruvananthapuram, India
Focus
Healthcare products
Scale
Major
Manufactures Moods and Nirodh brands
Veru Inc.
Headquarters
Miami, Florida, USA
Focus
Healthcare & biopharma
Scale
Major
Ansell Limited
Headquarters
Richmond, Victoria, Australia
Focus
Protection solutions
Scale
Global
Sells condoms under various brands
TTK Protective Devices Limited
Headquarters
Chennai, India
Focus
Condom manufacturing
Scale
Major
Guilin Latex Co., Ltd.
State-owned Chinese manufacturer
Humanwell Healthcare Group Co., Ltd.
Headquarters
Wuhan, China
Focus
Pharmaceuticals & medical devices
Scale
Major
Cupid Limited
Headquarters
Mumbai, India
Focus
Condom & sexual wellness products
Scale
Major
Mithra Pharmaceuticals SA
Headquarters
Liege, Belgium
Focus
Women’s health
Scale
Major
Recommended posts
Free Data: Condoms – World
Instant access. No credit card needed.
